Performance of the CryoValve* SG human decellularized pulmonary valve in 342 patients relative to the conventional CryoValve at a mean follow-up of four years

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 2, 2010, Pages 339-348

  Brown, John W ^a   Elkins, Ronald C ^b   Clarke, David R ^c   Tweddell, James S ^d   Huddleston, Charles B ^e   Doty, John R ^f   Fehrenbacher, John W ^g   Takkenberg, Johanna J M ^h  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^e ST LOUIS CHILDREN S HOSPITAL   (United States)

^f INTERMOUNTAIN MEDICAL CENTER   (United States)

^g METHODIST HOSPITAL   (United States)

^h ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ALLOGRAFT; ARTICLE; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; HEART FAILURE; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMAN; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY VALVE; ROSS PROCEDURE; SURVIVAL TIME;

ADULT; CRYOPRESERVATION; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PULMONARY VALVE; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 74549163779     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.04.065     Document Type: Article

References (31)

1. Kouchoukos N.T., Masetti P., Nickerson N.J., Castner C.F., Shannon W.D., and Davila-Roman V.G. The Ross procedure: long-term clinical and echocardiographic follow-up. Ann Thorac Surg 78 (2004) 773-781
2. Dearani J.A., Orszulak T.A., Schaff H.V., Daly R.C., Anderson B.J., and Danielson G.K. Results of allograft aortic valve replacement for complex endocarditis. J Thorac Cardiovasc Surg 113 (1997) 285-291
3. Niwaya K., Knott-Craig C.J., Lane M.M., Chandrasekaren K., Overholt E.D., and Elkins R.C. Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg 117 (1999) 141-146
4. O'Brien M.F., Harrocks S., Stafford E.G., Gardner M.A., Pohlner P.G., Tesar P.J., et al. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 10 (2001) 334-344
5. Oswalt J.D., Dewan S.J., Mueller M.C., and Nelson S. Highlights of a ten-year experience with the Ross procedure. Ann Thorac Surg 71 5 Suppl (2001) S332-S335
6. Takkenberg J.J., Dossche K.M., Hazekamp M.G., Nijveld A., Jansen E.W., Waterbolk T.W., et al. Report of the Dutch experience with the Ross procedure in 343 patients. Eur J Cardiothorac Surg 22 (2002) 70-77
7. Tweddell J.S., Pelech A.N., Frommelt P.C., Mussatto K.A., Wyman J.D., Fedderly R.T., et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 102 19 Suppl. 3 (2000) III130-III135
8. Baskett R.J., Ross D.B., Nanton M.A., and Murphy D.A. Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?. J Thorac Cardiovasc Surg 112 (1996) 1170-1178
9. Dignan R., O'Brien M., Hogan P., Thornton A., Fowler K., Byrne D., et al. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. J Heart Valve Dis 12 (2003) 382-390
10. Hawkins J.A., Breinholt J.P., Lambert L.M., Fuller T.C., Profaizer T., McGough E.C., et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 119 (2000) 324-330
11. Smith J.D., Hornick P.I., Rasmi N., Rose M.L., and Yacoub M.H. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. Ann Thorac Surg 66 6 Suppl (1998) S212-S215
12. Clarke D.R., Campbell D.N., Hayward A.R., and Bishop D.A. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 105 (1993) 934-941
13. Bechtel J.F., Muller-Steinhardt M., Schmidtke C., Brunswik A., Stierle U., and Sievers H.H. Evaluation of the decellularized pulmonary valve homograft (SynerGraft). J Heart Valve Dis 12 (2003) 734-739
14. Zehr K.J., Yagubyan M., Connolly H.M., Nelson S.M., and Schaff H.V. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results. J Thorac Cardiovasc Surg 130 (2005) 1010-1015
15. Elkins R.C., Lane M.M., Capps S.B., McCue C., and Dawson P.E. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg 13 4 Suppl. 1 (2001) 82-86
16. Hawkins J.A., Hillman N.D., Lambert L.M., Jones J., Di Russo G.B., Profaizer T., et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg 126 (2003) 247-252
17. Akins C.W., Miller D.C., Turina M.I., Kouchoukos N.T., Blackstone E.H., Grunkemeier G.L., et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 135 (2008) 732-738
18. Goldstein S, Black KS, inventors; CryoLife, Inc., assignee. Tissue decellularization. United States patent US 7318998. 2008 Jan 15.
19. McNally RT, Heacox A, Brockbank KG, Bank HL, inventors; CryoLife, Inc., assignee. Method for cryopreserving heart valves. United States patent US 4890457. 1990 Jan 2.
20. Elkins R.C., Dawson P.E., Goldstein S., Walsh S.P., and Black K.S. Decellularized human valve allografts. Ann Thorac Surg 71 5 Suppl (2001) S428-S432
21. Capps S.B., Elkins R.C., and Fronk D.M. Body surface area as a predictor of aortic and pulmonary valve diameter. J Thorac Cardiovasc Surg 119 (2000) 975-982
22. Clark T.G., Altman D.G., and De Stavola B.L. Quantification of the completeness of follow-up. Lancet 359 (2002) 1309-1310
23. Yap C.H., and Yii M. Allograft aortic valve replacement in the adult: a review. Heart Lung Circ 13 (2004) 41-51
24. Smith J.D., Ogino H., Hunt D., Laylor R.M., Rose M.L., and Yacoub M.H. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 60 2 Suppl (1995) S127-S130
25. Forbess J.M., Shah A.S., St Louis J.D., Jaggers J.J., and Ungerleider R.M. Cryopreserved homografts in the pulmonary position: determinants of durability. Ann Thorac Surg 71 (2001) 54-59
26. Brown J.W., Ruzmetov M., Rodefeld M.D., Vijay P., and Turrentine M.W. Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 80 (2005) 655-663
27. Gerestein C.G., Takkenberg J.J., Oei F.B., Cromme-Dijkhuis A.H., Spitaels S.E., van Herwerden L.A., et al. Right ventricular outflow tract reconstruction with an allograft conduit. Ann Thorac Surg 71 (2001) 911-917
28. O'Brien M.F., Goldstein S., Walsh S., Black K.S., Elkins R., and Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 11 (1999) 194-200
29. Tavakkol Z., Gelehrter S., Goldberg C.S., Bove E.L., Devaney E.J., and Ohye R.G. Superior durability of SynerGraft pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg 80 (2005) 1610-1614
30. Bechtel J.F., Gellissen J., Erasmi A.W., Petersen M., Hiob A., Stierle U., et al. Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts. Eur J Cardiothorac Surg 27 (2005) 410-415
31. Bechtel J.F., Stierle U., and Sievers H.H. Fifty-two months' mean follow up of decellularized SynerGraft-treated pulmonary valve allografts. J Heart Valve Dis 17 (2008) 98-104